Form 8-K - Current report:
SEC Accession No. 0001564590-22-006711
Filing Date
2022-02-24
Accepted
2022-02-24 16:16:02
Documents
13
Period of Report
2022-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pstv-8k_20220224.htm   iXBRL 8-K 32945
2 EX-99.1 pstv-ex991_6.htm EX-99.1 367467
  Complete submission text file 0001564590-22-006711.txt   547368

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pstv-20220224.xsd EX-101.SCH 5725
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20220224_lab.xml EX-101.LAB 19426
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20220224_pre.xml EX-101.PRE 11610
7 EXTRACTED XBRL INSTANCE DOCUMENT pstv-8k_20220224_htm.xml XML 3550
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 22671166
SIC: 3841 Surgical & Medical Instruments & Apparatus